Korth, C.; Mullington, J.; Schreiber, W.; Pollmächer, T.: Influence of endotoxin on daytime sleep in humans. Infection and Immunity 64, pp. 1110 - 1115 (1996)

Kubota, M.; Landgraf, R.; Wotjak, C. T.: Release of vasopressin within the rat suprachiasmatic nucleus. No effect of a V1/V2 antagonist. NeuroReport 7, pp. 1933 - 1936 (1996)

Lammers, C.-H.; Heuser, I.: Hypothalamic-pituitary-adrenal axis in schizophrenia. Biological Psychiatry 40, p. 561 - 561 (1996)

Lancel, M.; Crönlein, T. A. M.; Faulhaber, J.: Role of GABA-A receptors in sleep regulation: differential effects of muscimol and midazolam on sleep in rats. Neuropsychopharmacology 15, pp. 63 - 74 (1996)

Lancel, M.; Faulhaber, J.: The GABA-A agonist THIP (gaboxadol) increases non-REM sleep and enhances delta activity in the rat. NeuroReport 7, pp. 2241 - 2245 (1996)

Lancel, M.; Faulhaber, J.; Holsboer, F.; Rupprecht, R.: Progesterone induces changes in sleep EEG comparable to those of agonistic GABA_Α receptor modulators. American Journal of Physiology 271, pp. E763 - E772 (1996)

Lancel, M.; Mathias, S.; Faulhaber, J.; Schiffelholz, T.: Effect of interleukin-1 ß on EEG power density during sleep depends on circadian phase. American Journal of Physiology 270, pp. R 830 - R 837 (1996)

Landgraf, R.: Antisense targeting in behavioural neuroendocrinology. Journal of Endocrinology 151, pp. 333 - 340 (1996)

Lezoualc`h, F.; Rupprecht, R.; Holsboer, F.; Behl, C.: Bcl-2 overexpression blocks the toxicity of haloperidol in hippocampal neurons. Brain Research 738, pp. 176 - 179 (1996)

Lezoualc`h, F.; Skutella, T.; Widmann, M.; Behl, C.: Melatonin prevents oxidative stress-induced cell death in hippocampal cells. NeuroReport 7, pp. 2071 - 2077 (1996)

Liebsch, G.; Wotjak, C. T.; Landgraf, R.; Engelmann, M.: Septal vasopressin modulates anxiety-related behaviour in rats. Neuroscience Letters 217, pp. 101 - 104 (1996)

Linthorst, A. C. E.; Flachskam, C.; Holsboer, F.; Reul, J. M. H. M.: Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin involvement of the cyclooxygenase pathway. Neuroscience 72, pp. 989 - 997 (1996)

Lovinger, D. M.; Zieglgänsberger, W.: Interactions between ethanol and drugs that act on the NMDA receptor. Alcoholism: Clinical and Experimental Research 20, pp. 187 - 191 (1996)

Ludwig, M.; Callahan, M. F.; Landgraf, R.; Johnson, A. K.; Morris, M.: Neural input modulates osmotically stimulated release of vasopressin into the supraoptic nucleus. American Journal of Physiology 270, pp. E 787 - E 792 (1996)

Madamba, S. G.; Schweitzer, P.; Zieglgänsberger, W.; Siggins, G. R.: Acamprosate (Calcium Acetylhomotaurinate) enhances the N-Methyl-D-Aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro. Alcoholism: Clinical and Experimental Research 20, pp. 651 - 65 8 (1996)

Magee, W. J.; Eaton, W. W.; Wittchen, H.-U.; McGonagle, K. A.; Kessler, A. C.: Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Archives of General Psychiatry 53, pp. 159 - 168 (1996)

Marshall, L.; Mölle, M.; Böschen, G.; Steiger, A.; Fehm, H. L.; Born, J.: Greater efficacy of episodic than continuous growth hormone releasing hormone (GHRH) administration in promoting slow wave sleep (SWS). Journal of Clinical Endocrinology & Metabolism 81, pp. 1009 - 1013 (1996)

Merikangas, K.; Angst, J.; Eaton, W.; Canino, G.; Rubio-Stipec, M.; Wacker, H.; Wittchen, H.-U.; Andrade, L.; Essau, C. A.; Kraemer, H. et al.; Robins, L.; Kupfer, D.: Comorbidity and boundaries of affective disorders with anxiety disorders and substance abuse: Results of an international task force. British Journal of Psychiatry 168 (Suppl. 30), pp. 49 - 58 (1996)

Montkowski, A.; Holsboer, F.: Transgene Tiermodelle in der psychiatrischen Forschung. Neuroforum 1, pp. 25 - 31 (1996)

Mullington, J.; Hermann, D.; Holsboer, F.; Pollmächer, T.: Age-dependent suppression of nocturnal growth hormone levels during sleep deprivation. Neuroendocrinology 64, pp. 233 - 241 (1996)